Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 26 of 26 publications.

Anderson SA, Bian B, Talbird SE, Stratton M, Maxwell R, Ferries R. Medical cost and healthcare resource utilization offset for zuranolone relative to SSRIs in the treatment of postpartum depression. Poster presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2024; October 14, 2024. Las Vegas, NV.

Fishman J, Anderson S, Talbird SE, Dingli D. Analysis of costs per responder in US adults with a paroxysmal nocturnal hemoglobinuria with suboptimal response to prior eculizumab treatment. Hematol Rep. 2023 Oct 13;15(4):578-91. doi: 10.3390/hematolrep15040060

Talbird SE, Anderson SA, Nossov M, Beattie N, Rak AT, Diaz-Mitoma F. Cost-effectiveness of a 3-antigen versus single-antigen vaccine for the prevention of hepatitis b in adults in the United States. Vaccine. 2023 May 26;41(23):3506-17. doi: 10.1016/j.vaccine.2023.04.022

Hicks KA, Ghaswalla P, Carrico J, Anderson S, Novy P, Hogea C, Hayney MS. Estimating the cost of university-based outbreaks of serogroup B meningococcal disease with different pre-matriculation vaccination policies in the United States. J Am Coll Health. 2023 Jan 26. doi: 10.1080/07448481.2022.2163854

Talbird S, Graham J, Anderson S, Nossov M, Beattie N, Lains Sousa C, Rak A, Masters III H, Diaz-Mitoma F. Health and economic impact of a novel 3-antigen vaccine for the prevention of hepatitis B in adults in Germany: a cost-effectiveness analysis. Poster presented at the ISPOR Europe 2022; November 8, 2022. Vienna, Austria. [abstract] Value Health. 2022 Dec 1; 25(12):S135. doi: 10.1016/j.jval.2022.09.649

Talbird S, Graham J, Anderson S, Nossov M, Beattie N, Lains Sousa C, Rak A, Masters III H, Diaz-Mitoma F. Cost-effectiveness and epidemiological impact of a novel 3-antigen vaccine for the prevention of Hepatitis B in adults in the United Kingdom. Poster presented at the ISPOR Europe 2022; November 8, 2022. Vienna, Austria. doi: 10.1016/j.jval.2022.09.782

Guynn I, Simon J, Anderson S, Klaman SL, Mullenix A, Cilenti D, Hassmiller Lich K. Tools for supporting the MCH Workforce in addressing complex challenges: a scoping review of system dynamics modeling in maternal and child health. Matern Child Health J. 2022 Aug;26(Suppl 1):S176-203. doi: 10.1007/s10995-022-03376-8

Anderson S, Talbird SE, Nossov M, Beattie N, Diaz-Mitoma F. Cost-effectiveness of 3-antigen vs. single-antigen vaccine for prevention of hepatitis B in adults in the United States. Poster presented at the ISPOR 2022 Conference; May 15, 2022. Washington, DC. [abstract] Value Health. 2022 Jun; 25(6 S1).

Anderson S, Mauskopf J, Talbird SE, White A, Meenakshi S. Antiseizure medications and oral contraceptives: impact of enzyme inducers on pregnancy outcomes and costs. Epilepsy Behav. 2021 Dec;125:108368. doi: 10.1016/j.yebeh.2021.108368

Anderson S, Talbird SE, Fishman J, Mody-Patel N, Sarda SP. Budget impact of pegcetacoplan, a complement c3 inhibitor, for the treatment of paroxysmal nocturnal hemoglobinuria in US adults. Poster presented at the Virtual ISPOR Europe 2021; November 30, 2021. [abstract] Value Health. 2021 Dec; 24(12):S2.

Anderson S, Carrico J, Brodtkorb T-H, Lalla D, Brufsky A. Budget impact of introducing neratinib for third-line treatment of human epidermal growth factor receptor 2 positive metastatic breast cancer in the United States. Poster presented at the 2021 Virtual AMCP; April 12, 2021. Previously presented at the 2020 Virtual San Antonio Breast Cancer (SABCS) Meeting.

La E, Poston S, Curran D, Lorenc S, Salem AE, Carrico J, Hicks KA, Anderson S, Carpenter CF. Cost-effectiveness analysis of recombinant zoster vaccine for vaccinating immunocompromised adults against Herpes Zoster in the United States. Presented at the ACIP Herpes Zoster Working Group; April 2021. Atlanta, GA.

Hicks KA, Ghaswalla P, Carrico J, Anderson S, Novy P, Hogea C, Hayney MS. Estimations of the cost of university-based outbreaks of serogroup B meningococcal disease in the United States. Poster presented at the Pediatric Academic Societies (PAS) 2021 Virtual Meeting; April 2021.

Anderson S, Talbird S, Fishman J. Cost per responder analysis for pegcetacoplan and eculizumab in the treatment of adults with paroxysmal nocturnal hemoglobinuria. Blood. 2021;138(Suppl 1):4956. doi: 10.1182/blood-2021-153190

Anderson S, Carrico J, Brodtkorb T-H, Lalla D, Brufsky A. Budget impact of introducing neratinib for third-line treatment of HER2+ metastatic breast cancer in the United States. Poster presented at the 2020 Virtual San Antonio Breast Cancer (SABCS) Meeting; December 9, 2020.

Clienti D, Issel M, Wells R, Link (Anderson) S, Lich KH. System dynamics approaches and collective action for community health: an integrative review. Am J Community Psychol. 2019 Jun;63(3-4):527-45. doi: 10.1002/ajcp.12305

Anderson S, Frerichs L, Kaysin A, Wheeler SB, Halpern CT, Lich KH. Effects of two educational posters on contraceptive knowledge and intentions: a randomized controlled trial. Obstet Gynecol. 2019 Jan;133(1):53-62. doi: 10.1097/AOG.0000000000003012

Anderson S, Barry M, Frerichs L, Wheeler SB, Halpern CT, Kaysin A, Lich KH. Cognitive interviews to improve a patient-centered contraceptive effectiveness poster. Contraception. 2018 Dec;98(6):528-34. doi: 10.1016/j.contraception.2018.06.010

Anderson S, Halpern CT. Characterizing pregnancy scares and their association with perceived infertility. Poster presented at the 2018 Population Association of America Meeting; April 27, 2018. Denver, CO. doi: 10.1002/ajcp.12305

Calancie L, Anderson S, Branscomb J, Apostolico AA, Hassmiller Lich K. Using behavior over time graphs to spur systems thinking among public health practitioners. Prev Chronic Dis. 2018 Feb 1;15:E16. doi: 10.5888/pcd15.170254

Halpern CT, Hassmiller Lich K, Anderson S. Demographic correlates of U.S. pregnancy scares from 2006-2013. Presented at the 2017 Population Association of America (PPA) Meeting; April 28, 2017. Chicago, IL.

Wilkinson A, Anderson S, Wheeler SB. Screening for and treating postpartum depression and psychosis: a cost-effectiveness analysis. Matern Child Health J. 2017 Apr;21(4):903-14. doi: 10.1007/s10995-016-2192-9

Hassmiller Lich K, Anderson S, Branscomb J, Calancie L. It's a matter of time: using trend graphs to build understanding and choose smart strategies. Presented at the 2016 Maternal and Child Health (MCH) Summer Skills Institute; August 25, 2016.

Hassmiller Lich K, Calancie L, Collins S, Anderson S, Chaudhry A, Cox S, Ewy S. Planning and supporting collaborative initiatives: using system support mapping to coordinate action. Presented at the 2016 Maternal and Child Health (MCH) Summer Skills Institute; August 23, 2016.

Anderson S, Hassmiller Lich K, Collins S, Calancie L. Expanding your thinking about sweet spots for change with the levels of leverage framework. Presented at the 2016 Maternal and Child Health (MCH) Summer Skills Institute; August 22, 2016.

Anderson S, Orton S, Cilenti D. Achieving collective impact through adaptive leadership and systems mapping. Presented at the 2015 CityMatCH Annual Urban MCH Leadership Conference; September 2015. Salt Lake City, UT.